Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries

University of Arizona

Status: Completed

Conditions: Gastrointestinal Injury; Complicated Diverticulitis

Treatments: Device: "Veraflo" device, Dakin's solution

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02127164

UAKCI2014

Details and patient eligibility

About

Emergent abdominal surgeries have very high rate of wound contamination due to exposure to bacteria from GI tract. There are several different approaches to wound management in these patients including wet-to-dry dressing or application vacuum assisted device on the wound. The investigators propose using the vacuum assisted device with Dakin's solution on patients undergoing emergency surgery for hollow viscus perforation installed immediately at the end of operation and remained there for the first 3 postoperative days, followed by delayed primary closure on postoperative day 4. The investigators believe this technique can achieve earlier wound closure, decrease patient discomfort, improve cost savings, and potentially standardize and revolutionize the investigators management of heavily contaminated wounds.

Enrollment: 18 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Emergent surgery involving hollow viscus perforation or necrotic bowel
• Admitted to the University of Arizona Medical Center, Tucson, AZ

Exclusion criteria

• Prisoners
• Pregnancy
• Patients with allergy to Dakin's (sodium hypochlorite) solution.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

18 participants in 1 patient group

"Veraflo" device, Dakin's solution

Experimental group

Treatment:

Device: "Veraflo" device, Dakin's solution